Clinical trial
Diltiazem vs. Metoprolol in the Acute Management of Atrial Fibrillation in Patients With Heart Failure With Reduced Ejection Fraction
NCT02938260 is registered in ClinicalTrials.gov with RaeAnn Hirschy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diltiazem vs. Metoprolol in the Acute Management of Atrial Fibrillation in Patients With Heart Failure With Reduced Ejection Fraction
- Lead sponsor
- RaeAnn Hirschy
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- March 31, 2017
- Enrollment
- 48 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.